A phase II trial of oral gimatecan for recurrent glioblastoma.
Hu J; Wen PY; Abrey LE; Fadul CE; Drappatz J; Salem N; Supko JG; Hochberg F; Journal Of Neuro-Oncology, 2013, vol. 111, issue 3, p 347, ISSN 15737373. ISBN 15737373.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef